SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-032759
Filing Date
2023-07-13
Accepted
2023-07-13 07:07:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A itrm_defa14a_letter_call.htm DEFA14A 49727
2 GRAPHIC img214826273_0.jpg GRAPHIC 6275
3 GRAPHIC img214826273_1.jpg GRAPHIC 6275
4 GRAPHIC img214826273_2.jpg GRAPHIC 2439
  Complete submission text file 0000950170-23-032759.txt   71940
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38503 | Film No.: 231085728
SIC: 2834 Pharmaceutical Preparations